John C. Rewcastle
Papers
1
Total Citations
225
H-Index
1
About
John C. Rewcastle is a leading figure in the development and clinical translation of advanced prostate cancer imaging and focal therapy. His research centers on the precise characterization of prostate tumors, particularly through the integration of magnetic resonance imaging (MRI) and transrectal ultrasound (TRUS) for targeted biopsies. His landmark 2014 study, cited over 225 times, demonstrated that MRI-TRUS fusion biopsies accurately characterize the index tumor when correlated with step-sectioned radical prostatectomy specimens, fundamentally improving diagnostic accuracy and treatment planning. Rewcastle’s work has been instrumental in moving prostate cancer management away from whole-gland treatments toward more targeted, organ-sparing approaches. He has also contributed significantly to the development of focal therapies, including cryoablation and high-intensity focused ultrasound, helping to establish evidence-based protocols that reduce side effects while maintaining oncologic control. With a career spanning clinical innovation and rigorous validation, Rewcastle’s research has shaped modern urologic oncology, offering patients more personalized and less invasive options. His contributions continue to influence how clinicians identify, characterize, and treat clinically significant prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1